Lab studies suggest the antibody treatment, one of the few shown to be effective against omicron, will still be effective against the BA.2 omicron variant, Vir’s chief executive said.
GSK, Vir Say Their Covid Antibody Treatment Can Neutralize Fast-Spreading Omicron Relative
